Performance Blend Capsules deliver CJC-1295 and Ipamorelin in oral form; the same dual growth hormone secretagogue combination available as an injectable, formulated for patients who prefer oral administration. Together these two compounds stimulate the pituitary through separate receptor pathways; producing a synergistic HGH response that supports body composition, sleep quality, bone density, cardiovascular health, and recovery.
CJC-1295 binds to GHRH receptors on the pituitary to sustain elevated growth hormone output; its Drug Affinity Complex modification provides a longer duration of action than standard GHRH analogs.
Ipamorelin activates ghrelin receptors through a separate pathway; stimulating pulsatile GH release that mirrors the body's natural hormonal rhythm while maintaining high selectivity for GH over cortisol and prolactin. The two compounds' complementary mechanisms produce a more complete GH stimulation profile than either achieves independently.
RegenMD providers establish your oral dosing protocol based on your hormonal profile and goals, available in 30 and 60-count formulations.
See injectable Performance Blend →